Understanding ICD-10-CM coding for secondary malignant neoplasm of the skin on the chin

Explore how ICD-10-CM differentiates metastatic skin involvement on the chin. This guide compares C79.31 and C79.2, clarifying when each code is used and how precise site-specific coding helps capture the cancer’s spread and location accurately.

Multiple Choice

What ICD-10-CM code represents secondary malignant neoplasm of skin of the chin?

If you’ve ever wrestled with ICD-10-CM codes, you know there are moments when a single letter and a handful of digits can feel like a tiny puzzle box. The question “What code nails a secondary malignant neoplasm of the skin at the chin?” isn’t just trivia. It’s about precision, anatomy, and how the code set guides clinicians, coders, and health systems toward clarity. Let’s unpack the nuance without getting lost in the noise.

The basics you already know (or should know by now)

Secondary malignant neoplasm means the cancer has spread from its primary site to another location. In ICD-10-CM, the “secondary” or metastatic neoplasms are coded with a prefix C79, but there’s more texture to the digits that follows.
The skin as a site gets its own family of codes when the malignancy metastasizes specifically to the skin. The more precise you can be about location, the better the clinical picture is captured for research, billing, and care coordination.

Let’s get literal about the chin

When we say “secondary malignant neoplasm of the skin of the chin,” we’re describing a metastasis whose skin involvement is not just anywhere on the body but localized to the chin region. In ICD-10-CM, that granularity lives in the later digits of the code. It’s not just about “skin” in general; it’s about the exact skin site that’s affected.

A quick map of the codes in question

C79.31: Secondary malignant neoplasm of skin of chin.
C79.2: Secondary malignant neoplasm of distant site (a broader umbrella, not specifying skin or chin).
C85.16: Non-Hodgkin lymphoma (not relevant to a skin metastasis, but it’s a reminder that the C codes cover a lot of blood cancers and their cousins).
E86.0: Dehydration (yes, a totally different category—this one is about fluid loss and isn’t at all about cancer spread).

If you’re aiming for a precise clinical picture, C79.31 is the one that slots the chin’s skin metastasis into the ICD-10-CM framework. It’s the suffix that pinpoints the anatomical site, not just the concept of metastasis. That specificity matters. It helps track patterns of spread, informs prognosis discussions, and supports insurers and health data analysts in pulling the right signals from a patient’s record.

Why the confusion happens

Some sources simplify metastatic codes as “C79.x” without drilling down to the exact site. That practice can be tempting when you’re skimming or cross-referencing quickly, but it’s a trap if you need precision.
The phrasing in your reference materials might drift between “secondary malignant neoplasm of skin” (C79.2) and “secondary malignant neoplasm of skin of chin” (C79.31). The way the digits are arranged is more than a cosmetic detail; it’s the difference between a general skin metastasis and one that’s specifically on the chin.

Here’s the thing: the structure of ICD-10-CM is built to capture that kind of specificity. The “C79” block covers secondary malignant neoplasms in general. The next digits guide you to the organ or tissue class, and the final digits zero in on a precise site when needed. In this case, adding “skin of chin” is what makes C79.31 come to life for clinicians and coders alike.

How this plays out in practice

Documentation drives the code. If the clinician notes are clear—“metastasis to the skin of the chin from a primary cancer located elsewhere”—the coder can apply C79.31 with confidence. If the note only says “skin metastasis,” you may have to scan for more detail or use a broader code while flagging for more specificity later.
Payers and public health data appreciate the nuance. A code that explicitly says “chin skin” helps track lesion patterns across populations, which in turn informs research on metastasis pathways and treatment efficacy.
Coding audits love specifics. When the chart shows C79.31, auditors can verify that the site-of-metastasis coding aligns with the clinical notes, reducing the risk of misclassification.

A gentle digression—why location matters beyond the paperwork

Let’s pause a moment and think about what it would feel like to have metastasis localized to a spot like the chin. It’s not just a medical label; it’s about real-world implications: a dermatologist consulted for a facial lesion, a surgeon planning a skin-directed intervention, and an oncologist coordinating systemic therapy. The chin isn’t just “skin”; it’s a region near the jawline with distinct cosmetic and functional considerations. The coding system mirrors that nuance, not to complicate things for the sake of it, but to reflect the clinical reality as faithfully as possible. That fidelity pays off in patient care pathways, even if it sounds a bit dry on the page.

Common pitfalls to watch for (and how to sidestep them)

Don’t default to C79.2 when the documentation specifies a site. If the chart says skin of the chin, go for C79.31.
If the note reads “skin metastasis” without a site, you may need to query for location. It’s better to pause and clarify than to guess.
Cross-check laterality and regional anatomy only if the notes mention it. In some coding systems, laterality isn’t always needed for skin metastases, but when a site is specified, that detail can matter for other coding layers—like procedures or treatment codes.

How to keep your code choices clean (a practical mindset)

Read the site, then the disease concept. If it’s the skin, identify the body region first (chin, leg, scalp, etc.). The site often cascades into the right code.
Look for cues in the clinical notes. Phrases like “secondary to [primary cancer]” and “skin metastasis to the chin” are your road signs.
When in doubt, escalate. A quick consult with the clinician or a more detailed note review can save you from misclassification. It’s a tiny moment that prevents headaches later in data reporting or billing.

A note on the broader ICD-10-CM landscape

Codes like C79.31 live in a sprawling ecosystem. The system is designed to capture the patient’s journey with a level of precision that supports everything from treatment planning to epidemiological research. It’s not just about ticking boxes; it’s about telling a story with accuracy. And that story matters—for the patient, for the care team, and for the records that help health systems learn and adapt.

What to remember, in plain terms

If the metastasis is specifically described as involving the skin of the chin, the right code is C79.31.
C79.2 is a broader umbrella for secondary malignant neoplasms of the skin in general or in a less specific location.
The digits aren’t arbitrary. They’re a map—one that helps clinicians and researchers understand exactly where cancer has settled.

A final thought

Coding isn’t a test you pass once and forget. It’s a living language that keeps pace with anatomy, pathology, and patient care needs. The more you embrace the details—the precise site, the nature of metastasis—the more you can contribute to a cleaner, more useful medical record. And while the line between C79.31 and C79.2 might look tiny, that line carries a real weight: it’s the difference between a record that says “skin metastasis” and one that says “secondary malignant neoplasm of the skin of the chin.” The distinction matters. It’s the kind of precision that turns data into understanding, and that’s what clever coding is all about.